Could a Type 2 Diabetes Drug Tackle Kidney Stones?
A pooled data analysis of trials of the SGLT2 inhibitor empagliflozin in type 2 diabetes suggests it may lower the risk of kidney stones. However, this is early research.
United States New Haven Kasperb Kristensen Priyadarshini Balasubramanian University Of Southern Denmark Yale School Of Medicine
Source: medscape.com